447 related articles for article (PubMed ID: 20410852)
41. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
[TBL] [Abstract][Full Text] [Related]
42. Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients.
Kaufmann RA; Oberholzer PA; Cazzaniga S; Hunger RE
Eur J Dermatol; 2016 Jun; 26(3):265-70. PubMed ID: 26985913
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
Stern RS
Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
[TBL] [Abstract][Full Text] [Related]
44. Aggressive squamous cell carcinomas in organ transplant recipients.
Euvrard S; Kanitakis J; Pouteil-Noble C; Disant F; Dureau G; Finaz de Villaine J; Claudy A; Thivolet J
Transplant Proc; 1995 Apr; 27(2):1767-8. PubMed ID: 7725494
[No Abstract] [Full Text] [Related]
45. Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients.
Lott DG; Manz R; Koch C; Lorenz RR
Transplantation; 2010 Sep; 90(6):683-7. PubMed ID: 20808266
[TBL] [Abstract][Full Text] [Related]
46. Low incidence of neoplasia in heart and heart-lung transplant recipients receiving triple-drug immunosuppression.
Olivari MT; Diekmann RA; Kubo SH; Braunlin E; Jamieson SW; Ring WS
J Heart Transplant; 1990; 9(6):618-21. PubMed ID: 2277297
[TBL] [Abstract][Full Text] [Related]
47. Immune phenotype of peripheral blood cells and skin squamous cell carcinoma in organ transplant recipients.
Dziunycz P; Hofbauer GF
Expert Rev Clin Immunol; 2010 May; 6(3):359-62. PubMed ID: 20441422
[TBL] [Abstract][Full Text] [Related]
48. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients.
Gruber SA; Gillingham K; Sothern RB; Stephanian E; Matas AJ; Dunn DL
Clin Transplant; 1994 Aug; 8(4):388-95. PubMed ID: 7949545
[TBL] [Abstract][Full Text] [Related]
49. Sunscreen use before and after transplantation and assessment of risk factors associated with skin cancer development in renal transplant recipients.
Moloney FJ; Almarzouqi E; O'Kelly P; Conlon P; Murphy GM
Arch Dermatol; 2005 Aug; 141(8):978-82. PubMed ID: 16103326
[TBL] [Abstract][Full Text] [Related]
50. Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients.
Fryer AA; Ramsay HM; Lovatt TJ; Jones PW; Hawley CM; Nicol DL; Strange RC; Harden PN
Carcinogenesis; 2005 Jan; 26(1):185-91. PubMed ID: 15459020
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression.
Maurer TA; Christian KV; Kerschmann RL; Berzin B; Palefsky JM; Payne D; Tyring SK; Berger TG
Arch Dermatol; 1997 May; 133(5):577-83. PubMed ID: 9158410
[TBL] [Abstract][Full Text] [Related]
52. Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.
Pinho A; Gouveia M; Cardoso JC; Xavier MM; Vieira R; Alves R
An Bras Dermatol; 2016; 91(4):455-62. PubMed ID: 27579740
[TBL] [Abstract][Full Text] [Related]
53. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
[TBL] [Abstract][Full Text] [Related]
54. Incidence and types of malignancies in renal transplant recipients in Iraq.
Altaee IK; Jaleel NA; Aljubury HM; Alshamaa IA; Gazala S
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):408-14. PubMed ID: 16970265
[TBL] [Abstract][Full Text] [Related]
55. Head and neck cancer in cardiothoracic transplant recipients.
Pollard JD; Hanasono MM; Mikulec AA; Le QT; Terris DJ
Laryngoscope; 2000 Aug; 110(8):1257-61. PubMed ID: 10942122
[TBL] [Abstract][Full Text] [Related]
56. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients.
Ramsay HM; Fryer AA; Reece S; Smith AG; Harden PN
Am J Kidney Dis; 2000 Jul; 36(1):167-76. PubMed ID: 10873887
[TBL] [Abstract][Full Text] [Related]
57. Incidence and risk factors for skin cancer following lung transplantation.
Rashtak S; Dierkhising RA; Kremers WK; Peters SG; Cassivi SD; Otley CC
J Am Acad Dermatol; 2015 Jan; 72(1):92-8. PubMed ID: 25440431
[TBL] [Abstract][Full Text] [Related]
58. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
Ng JC; Cumming S; Leung V; Chong AH
Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
[TBL] [Abstract][Full Text] [Related]
59. Incidence of nonmelanoma skin cancer after human organ transplantation: single-center experience in Hungary.
Fekecs T; Kádár Z; Battyáni Z; Kalmár-Nagy K; Szakály P; Horváth OP; Wéber G; Ferencz A
Transplant Proc; 2010; 42(6):2333-5. PubMed ID: 20692474
[TBL] [Abstract][Full Text] [Related]
60. Incidence of cancer in kidney-transplant recipients: a long-term cohort study in a single center.
Wisgerhof HC; van der Geest LG; de Fijter JW; Haasnoot GW; Claas FH; le Cessie S; Willemze R; Bouwes Bavinck JN
Cancer Epidemiol; 2011 Apr; 35(2):105-11. PubMed ID: 20674538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
